Biotech company developing products for a safer return to businesses, workspaces post pandemic and last updated 2021-05-28 13:09:59-04 Inside a lab, doctors are developing innovative therapies for people with cancer or extreme pain. âAlmost any cancer antigen you can think of, we either have or can rapidly develop a fully human monoclonal antibody that targets that,â Dr. Mike Royal, Chief Medical Officer of Sorrento Therapeutics, said. But in 2020, biotech company Sorrento Therapeutics responded to the pandemic as well. âWe actually within a one year time will build the largest portfolio of products in the COVID-19 space,â Dr. Henry Ji, the CEO of Sorrento Therapeutics, said.